Biogen Message Board - Msg: 11778369

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 149.29

-1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Bong who wrote (1161)	11/2/1999 8:53:00 AM
From: Harold Engstrom	Read Replies (2) of 1686

Mark, per our conversation last night, here is a partial list of companies and drug candidates (besides Biogen and Amevive) pursuing psoraiasis indication. The database I use is slightly dated and some of these compounds may be further along or may have halted. There are certainly more companies and compounds chasing psoraisis than are shown below: Protein Design Labs: Zenapax (PIIb), SMART anti-CD3 (PII) IDEC: IDEC-114 (PII) CellGate: PI OSI Pharmaceuticals: preclinical Corixa: P-Vac, (PII) QLT: Visudyne (PIIb) Ligand: Tagretin (PII), Ontak (PII) Vertex: VX-497 (PII)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next